Treg versus Th17 lymphocyte lineages are cross-regulated by LIF versus IL-6

Cell Cycle

Volumn 8, Issue 9, 2009, Pages 1444-1450

  Gao, Wenda ^a   Thompson, Lorraine ^b   Zhou, Qiang ^a   Putheti, Prabhakar ^a   Fahmy, Tarek M ^c   Strom, Terry B ^a   Metcalfe, Su M ^b,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c YALE UNIVERSITY   (United States)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

IL 6; Immune regulation; Leukemia inhibitory factor; Nanotherapy; Th17; Treg

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR; NANOPARTICLE; TRANSCRIPTION FACTOR FOXP3; UBIQUITIN PROTEIN LIGASE E3;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CELL LINEAGE; CONTROLLED STUDY; CYTOKINE RELEASE; IMMUNOREGULATION; IN VIVO STUDY; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PARACRINE SIGNALING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RECIPIENT; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; SPLEEN CELL; TRANSCRIPTION REGULATION;

ERAGROSTIS TEF;

EID: 65949124869     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.8.9.8348     Document Type: Article

References (27)

1. Bromley SK, Burack WR, Johnson KG, Somersalo K, Sims TN, Sumen C, et al. The immunological synapse. Annu Rev Immunol 2001; 19:375-396
2. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006; 24:179-189 (Pubitemid 43214587)
3. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441:235-238
4. Bettelli E, Korn T, Kuchroo VK. Th17: the third member of the effector T cell trilogy. Curr Opin Immunol 2007; 19:652-657 (Pubitemid 350236805)
5. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008; 133:775-787
6. + regulatory T cells. Nat Immunol 2003; 4:330-336
7. + T regulatory cells. Nat Immunol 2003; 4:337-342
8. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299:1057-1061 (Pubitemid 36222930)
9. Hill JA, Feuerer M, Tash K, Haxhinasto S, Perez J, Melamed R, et al. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity 2007; 27:786-800. (Pubitemid 350110546)
10. Hori S. Rethinking the molecular definition of regulatory T cells. Eur J Immunol 2008; 38:928-930
11. Metcalfe SM, Watson TJ, Shurey S, Adams E, Green CJ. Leukemia inhibitory factor is linked to regulatory transplantation tolerance. Transplantation 2005; 79:726-730 (Pubitemid 40463181)
12. Bartee E, Mansouri M, Hovey Nerenberg BT, Gouveia K, Fruh K. Downregulation of major histocompatibility complex class I by human ubiquitin ligases related to viral immune evasion proteins. J Virol 2004; 78:1109-1120 (Pubitemid 38095821)
13. Metcalfe SM, Muthukumarana DSPA. Transplantation tolerance: gene expression profiles comparing allotolerance vs. allorejection. Int Immunopharmacol 2005; 5:33-39 (Pubitemid 39626681)
14. Metcalfe SM, Muthukumarana PA, Thompson HL, Haendel MA, Lyons GE. Leukemia inhibitory factor (LIF) is functionally linked to axotrophin and both LIF and axotrophin are linked to regulatory immune tolerance. FEBS Lett 2005; 579:609-614
15. Metcalfe SM. Axotrophin and leukemia inhibitory factor (LIF) in transplantation tolerance. Philos Trans R Soc Lond B Biol Sci 2005; 360:1687-1694 (Pubitemid 43997817)
16. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 2003; 374:1-20. (Pubitemid 37046923)
17. Metcalfe S, Moffatt-Bruce S. An ex vivo model of tolerance vs. rejection: comparison of different signal transducers and activators of transcription, STAT1, STAT4, STAT5 and STAT6. Clin Chem Lab Med 2000; 38:1195-1199 (Pubitemid 32007780)
18. Geberhiwot T, Assefa D, Kortesmaa J, Ingerpuu S, Pedraza C, Wondimu Z, et al. Laminin-8 (α4β1γ1) is synthesised by lymphoid cells, promotes lymphocyte migration and costimulates T cell proliferation. J Cell Sci 2001; 114:421-433
19. + T helper cells. Cell 2006; 126:1121-1133
20. Fahmy TM, Fong PM, Park J, Constable T, Saltzman WM. Nanosystems for simultaneous imaging and drug delivery to T cells. AAPS J 2007; 9:171-180 (Pubitemid 46939550)
21. Steenblock ER, Fahmy TM. A comprehensive platform for ex vivo T-cell expansion based on biodegradable polymeric artificial antigen-presenting cells. Mol Ther 2008; 16:765-772
22. +) cells during neonatal tolerance induction to Mlsa-encoded antigens. J Exp Med 1988; 167:2005-2010.
23. Blanchard F, Kinzie E, Wang Y, Duplomb L, Godard A, Held WA, et al. FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins. Oncogene 2002; 21:6264-6277
24. 24, Tao R, Zoeten EF, Ozkaynak E, Chen C, Wang L, Porrett PM, et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat Med 2007; 13:1305-1313 (Pubitemid 350073591)
25. Lu LF, Lind EF, Gondek DC, Bennett KA, Gleeson MW, Pino-Lagos K, et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 2006; 442:997-1002.
26. Muthukumarana P, Chae WJ, Maher S, Rosengard BR, Bothwell AL, Metcalfe SM. Regulatory transplantation tolerance and "stemness": evidence that Foxp3 may play a regulatory role in SOCS-3 gene transcription. Transplantation 2007; 84:6-11.
27. Chen Z, Cobbold SP, Waldmann H, Metcalfe S. Amplification of natural regulatory immune mechanisms for transplantation tolerance. Transplantation 1996; 62:1200-1206 (Pubitemid 27008539)